Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.4.0.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenue, net $ 3,035 $ 2,117
Cost of revenue (excluding amortization of $970 and $870, repectively) 1,179 1,574
Gross profit 1,856 543
Operating expenses:    
Sales and marketing 1,547 2,226
Research and development 323 232
General and administrative 2,816 3,339
Acquisition related amortization expense 970 870
Total operating expenses 5,656 6,667
Operating loss (3,800) (6,124)
Interest expense (203) (848)
Other income (expense), net 6 (86)
Loss from continuing operations before tax (3,997) (7,058)
Provision (benefit) for income tax 9 (73)
Loss from continuing operations (4,006) (6,985)
(Loss) income from discontinued operations, net of tax (780) 3,117
Net loss $ (4,786) $ (3,868)
Unrealized holding gain on available-for-sale securities, net
Comprehensive loss $ (4,786) $ (3,868)
Basic and diluted loss per share of common stock:    
From continuing operations (in dollars per share) $ (0.23) $ (0.46)
From discontinued operations (in dollars per share) (0.04) 0.21
Net loss per basic and diluted share of common stock (in dollars per share) $ (0.27) $ (0.26)
Weighted average number of common shares and common share equivalents outstanding:    
Basic weighted average number of common shares (in shares) 17,762 15,037
Diluted (in shares) 17,762 15,037